RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,301,245 | +163.3% | 144,002 | +89.4% | 0.00% | – |
| Q2 2023 | $1,253,636 | -79.9% | 76,024 | -78.3% | 0.00% | -100.0% |
| Q1 2023 | $6,237,560 | +7.4% | 349,639 | +75.3% | 0.00% | 0.0% |
| Q4 2022 | $5,809,527 | +2564.9% | 199,503 | +954.3% | 0.00% | – |
| Q1 2022 | $218,000 | -13.1% | 18,923 | +60.8% | 0.00% | – |
| Q1 2021 | $251,000 | -4.6% | 11,770 | +33.2% | 0.00% | – |
| Q4 2020 | $263,000 | +24.1% | 8,838 | -7.0% | 0.00% | – |
| Q2 2020 | $212,000 | +15.8% | 9,505 | -20.9% | 0.00% | – |
| Q1 2020 | $183,000 | -51.5% | 12,021 | -0.3% | 0.00% | -100.0% |
| Q2 2018 | $377,000 | – | 12,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |